Log in to save to my catalogue

Molecular-guided therapy for the treatment of patients with relapsed and refractory childhood cancer...

Molecular-guided therapy for the treatment of patients with relapsed and refractory childhood cancer...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracmisc_A782267806

Molecular-guided therapy for the treatment of patients with relapsed and refractory childhood cancers: a Beat Childhood Cancer Research Consortium trial

Publication information

Publisher

BioMed Central Ltd

More information

Scope and Contents

Contents

Children with relapsed central nervous system (CNS tumors), neuroblastoma, sarcomas, and other rare solid tumors face poor outcomes. This prospective clinical trial examined the feasibility of combining genomic and transcriptomic profiling of tumor samples with a molecular tumor board (MTB) approach to make real-time treatment decisions for childre...

Alternative Titles

Full title

Molecular-guided therapy for the treatment of patients with relapsed and refractory childhood cancers: a Beat Childhood Cancer Research Consortium trial

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_gale_infotracmisc_A782267806

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracmisc_A782267806

Other Identifiers

ISSN

1756-994X

E-ISSN

1756-994X

DOI

10.1186/s13073-024-01297-5

How to access this item